Emma Eriksson

Senior Advisor
M Med Sci, PhD

emma.eriksson@regsmart.se +46 (0) 70 255 75 31

Emma has over 12 years of experience in ATMP development at the interface between industry and academia, spanning drug substance and drug product development, manufacturing process development as well as pre-clinical and clinical development.

More about Emma

Her work has focused on developing product-specific analytical methods for characterization, release and stability testing and establishing assays to support preclinical and clinical endpoints. Emma is highly experienced with both cell-based assays and nucleic acid tests (NATs), ensuring that analytical approaches are fit-for-purpose and align with regulatory expectations.

Emma combines deep scientific knowledge and extensive hand-on technical experience with a comprehensive understanding of the regulatory requirements for ATMPs. She has practical experience preparing regulatory reports and writing dossier documentation.

Emma holds a PhD in cancer immunotherapy from the Department of Immunology, Genetics and Pathology at Uppsala University.